Matthias Grauert

USPTO Granted Patents = 74 (Patent Applications = 10)

CIPO Patents = 13

EPO Patents = 27 (Patent Applications = 18)

Average Co-Inventor Count = 5.0

ph-index = 19

Forward Citations = 976(Granted Patents)

Forward Citations (Not Self Cited) = 802(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Ingelheim am Rhein, DE (1991 - 2002)
Ingelheim, DE (1999 - 2002)
Biberach, DE (2004 - 2013)
Biberach an der Riss, DE (2014 - 2019)

Company Filing History:

47 out of 1,536

Boehringer Ingelheim International Gmbh

patents

10 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

8 out of 149

Boehringer Ingelheim Pharma Kg

patents

4. 8 out of 197

Boehringer Ingelheim Kg

patents

5. 1 out of 306

Boehringer Ingelheim Gmbh

patents

Years Active: 1991-2019

Loading Chart...

Areas of Expertise:

Substituted Spirocycles

Cathepsin C Inhibitors

Pulmonary Emphysema Treatment

Fibrotic Diseases

mGlu5 Receptor Modulators

PI3-Kinase Inhibitors

Dihydropteridione Derivatives

Piperazine Derivatives

Thiazolyl-Dihydro-Indazoles

Bronchodilators

Pharmaceutical Compositions

Nitrogen Heterocycles

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE47636 - Substituted spirocycles (2019-10-07),

2. 10238633 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2019-03-26),

3. 10154990 - Medicaments for the treatment or prevention of fibrotic diseases (2018-12-18),

4. 9879026 - Substituted spirocycles (2018-01-30),

5. 9713606 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2017-07-25),

6. 9540373 - Substituted spirocycles (2017-01-10),

7. 9440960 - Substituted oxetanes and their use as inhibitors of cathepsin C (2016-09-13),

8. 9243000 - Thia-triaza-indacenes (2016-01-26),

9. 9073869 - Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2015-07-07),

10. 8987249 - Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2015-03-24),

11. 8937176 - Compounds (2015-01-20),

12. 8889708 - Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2014-11-18),

13. 8889677 - Substituted triazoles useful as mGlu5 receptor modulators (2014-11-18),

14. 8877775 - Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2014-11-04),

15. 8846948 - Compounds (2014-09-30),

Title: The Innovative Mind of Matthias Grauert

Introduction: Matthias Grauert is a pioneering inventor hailing from Biberach, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Matthias Grauert holds several patents in the areas of renewable energy technologies, smart devices, and advanced manufacturing processes, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Matthias Grauert has worked tirelessly to transform his inventive ideas into tangible solutions that have the potential to revolutionize industries and improve the quality of life for many.

Collaborations: Throughout his career, Matthias Grauert has collaborated with leading research institutions, universities, and innovative companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Matthias Grauert's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his position as a visionary inventor shaping the future of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.